Skin Conditioning
LACTOBACILLUS EXTRACELLULAR VESICLES
Safety score · 0–100
Moderate
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
Extracellular vesicles (nanoscale lipid capsules) from Lactobacillus bacteria. Novel postbiotic ingredient — preliminary safety looks OK but regulation is catching up.
Lactobacillus extracellular vesicles are bacterial-origin nanovesicles (membrane vesicles, ≈30-300 nm) isolated from Lactobacillus culture supernatants. They are promoted as postbiotic skin actives for microbiome support, soothing and barrier repair. Unlike mammalian exosomes, bacterial-origin vesicles do not trigger human-tissue prohibitions; however, exosome/vesicle cosmetics as a class are under active regulatory scrutiny (EU and US FDA). No CIR or SCCS opinions exist; no standardised quality metrics; composition varies. Bacterial components (LPS analogues, cell-wall fragments) could theoretically drive immune reactions.
Function
Skin benefits
- Bacterial-origin vesicles claimed for microbiome support
- Postbiotic approach — no live organisms
- Potential soothing and barrier effects
Known concerns
- Novel ingredient class — no CIR or SCCS review
- Regulatory scrutiny of cosmetic vesicle/exosome products increasing
- Limited independent safety and efficacy data
- Proprietary composition variable between suppliers
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Related skin conditionings
Check your shelf
Find LACTOBACILLUS EXTRACELLULAR VESICLES in your products.
Scan any cosmetic product with LuxSense to see if it contains LACTOBACILLUS EXTRACELLULAR VESICLES and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.